Amphastar Pharmaceuticals Inc expected to post earnings of 48  cents a share - Earnings Preview

Amphastar Pharmaceuticals,

06/05/2023 03:09

* Amphastar Pharmaceuticals Inc  AMPH.OQ   AMPH.O  is
expected
to show a rise in quarterly revenue when it reports  results on
May 9. 
    * The Rancho Cucamonga California-based  company is expected
to
report  a 11.5% increase in revenue to $134.162 million from
$120.37 million a year ago, according to the mean estimate from
5 analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Amphastar
Pharmaceuticals
Inc is for earnings of 48 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 1.9%
in the last three months. ​
    * Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $41​, above​ its last closing price
of $36.49. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.40        0.41       0.73      Beat    79.7
 Sep. 30 2022  0.40        0.39       0.38      Missed  -3.6
 Jun. 30 2022  0.35        0.35       0.39      Beat    12.1​
 Mar. 31 2022  0.36        0.36       0.47      Beat    30.6
 ​​Dec.        0.33        0.36       0.42      Beat    16.1
 31 2021                                                
 Sep. 30 2021  0.25        0.24       0.46      Beat    89​
 Jun. 30 2021  0.22        0.21       0.21      Met     0.8
 Mar. 31 2021  0.18        0.18       0.27      Beat    46.5
 This summary was machine generated May 6 at 02:09 GMT.  All
figures in US dollars  unless otherwise stated